Antifungal Efficacy of Plant Essential Oils Against Candida, Aspergillus and Cryptococcus Species

Fungal diseases pose a severe threat, ranging from common skin infections resembling rashes to potentially deadly lung infections, particularly among individuals with asthma, HIV, COVID-19, diabetes, COPD, cancer, tuberculosis and those undergoing organ transplants and chemotherapy. Candida, Aspergillus, and Cryptococcus species contribute significantly to the healthcare burden, often leading to invasive infections and fatalities. While various antifungal drugs exist, their drawbacks, including side effects, limited efficacy, high costs and toxicity, persist as challenges. Researchers are actively exploring novel alternatives, with a growing interest in natural products, especially herbal remedies. Amid the COVID-19 pandemic, there has been a surge in people turning to natural products to boost their immune systems, drawing on a historical reliance on herbal remedies. Essential oils derived from plants, a practice dating back to ancient times, have demonstrated remarkable antifungal properties. Their high lipophilic nature and low molecular weight facilitate the disruption of fungal cell walls, allowing easy penetration through cell barriers. This chapter of the book aims to provide an updated understanding of Candidal, Aspergillus, and Cryptococcal infections, highlighting the limitations of current antifungal drugs while advocating for essential oils as promising substitutes based on compelling evidence from previous literature.